-
1 Comment
Ansell Limited is currently in a long term uptrend where the price is trading 7.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.0.
Ansell Limited's total revenue sank by 0.0% to $377M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $33M since the same quarter in the previous year.
Finally, its free cash flow fell by 50.3% to $16M since the same quarter in the previous year.
Based on the above factors, Ansell Limited gets an overall score of 2/5.
ISIN | AU000000ANN9 |
---|---|
Sector | Healthcare |
Exchange | F |
CurrencyCode | EUR |
Industry | Medical Instruments & Supplies |
Target Price | None |
---|---|
Beta | 0.44 |
Market Cap | 2B |
PE Ratio | 22.96 |
Dividend Yield | 2.5% |
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PD1A.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025